Kim Gwiadzdinski

Gwiadzdinski brings more than 20 years of direct market access experience holding key strategic positions at large national payers including Prime Therapeutics and Cigna. In her previous roles, Kim was responsible for driving the strategy and implementing both traditional and value-based agreements designed to lower overall costs. Kim’s experience spans beyond the payer world as she has also worked for industry leading pharmaceutical companies Merck, AstraZeneca and NovoNordisk, leading their efforts in pricing and contracting, commercial innovation, affordability, and population health.